Evaluation of an electronic Oral Glucose Tolerance Test Kit (eOGTTK)

Completed

• Conditions: Diabetes (type 2); Nutritional, Metabolic, Endocrine; Non-insulin-dependent diabetes mellitus

• Registration Number: ISRCTN91288133
• Lead Sponsor: ovartis Pharma AG (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Willing and able to give informed consent for participation in the study
2. Aged 18 years or above
3. Had adequate vision and reading comprehension to follow the electronic OGTT kit instructions in English
4. Patients with type 2 diabetes were:
4.1. Treated with diet alone or with metformin monotherapy
4.2. Had stable therapy for at least 3 months prior to study enrollment or
5. Individuals without diagnosed diabetes had no prior experience of an OGTT or any tests which involved finger-pricking

Exclusion Criteria

1. Pregnancy or planned pregnancy during the study period
2. Participant taking drugs that may affect glucose levels
3. History or current evidence of any condition, therapy, laboratory abnormality, or other circumstance which, in the opinion of the investigator, posed an unacceptable risk to the individual, confounded the results of the study, or was likely to interfere with the individual?s participation of the full duration of the trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified